Canada to Health Pros: All Finasteride Patients Should ‘Be Screened for Suicidal Ideation, Self-harm, and Depression’ Before Being Prescribed the Drug

Japanese disproportionality analysis of finasteride ADRs, meanwhile, shows completed suicides 270% higher than expected Jan. 28, 2024 Dear Friends: Canada is taking no chances vis-á-vis finasteride wreaking havoc on its citizens’ psyches. Pre-prescription edict Last week, drug-regulatory authority (DRA) Health Canada (HC), via its monthly Health Product InfoWatch bulletin, informed its nation’s healthcare professionals that: […]

Neuropsychiatric Side Effects for Finasteride Housed on FDA Database Show Disproportionate Safety Signals Compared to Control Meds—and a ‘Striking Increase in Suicides’—Says New Research

Following new safety review, Health Canada working with finasteride manufacturers to strengthen suicidality warning March 27, 2023 Dear Friends: Although the US Food and Drug Administration rarely mentions PFS, its database of side effects speaks volumes about the condition’s epidemiology. Out of control According to new research based in part on the agency’s Adverse Event […]

French Drug-Regulatory Authority Unveils World’s Most Thorough PFS-Prevention Program

‘How-to’ video encourages reporting of finasteride ADRs to Ministry of Health July 13, 2022 Dear Friends: France’s National Agency for the Safety of Medicines and Health Products (ANSM) last week published a dossier of educational materials on the growing number of adverse drug reactions (ADRs) to finasteride 1 mg, as experienced by men currently suffering […]

New PFS Global Warning Map Plots When, Where and How Drug Regulatory Authorities Alerted Public to Finasteride’s Potential Dangers

June 27, 2022 Dear Friends: The PFS Foundation has launched an interactive map plotting all the nations known to have issued warnings of finasteride’s potential to cause persistent adverse reactions, aka post-finasteride syndrome (PFS). Fifty-three nations, from Argentina to the United States, currently comprise our PFS Global Warning Map. Each links to a table entry […]

Regulatory Update: Canada Concludes ‘There May Be a Link Between Finasteride and Risk of Suicidal Ideation’

February 28, 2019 Dear Friends: Could Canada be thawing to the notion of a finasteride-free nation? Earlier this week, our neighbor to the north announced that Propecia and Proscar patients may be at risk for considering and attempting suicide, and mandated that the manufacturer update its product insert to reflect this potential danger. The move […]

Regulatory Update: ‘Muscle-related Disorders’ Added to Canadian Finasteride Label in Response to Report by FDA-equivalent Agency

July 28, 2018 Dear Friends: Canada has taken an important first step toward keeping its citizens apprised of finasteride’s many potentially serious and persistent side effects. In the June edition of its Health Product InfoWatch, Health Canada (Canada’s version of the US Food and Drug Administration) reported that “New information regarding the risk of muscle-related […]